ATLANTA, May 30, 2012 /PRNewswire/ -- Advanced automation, sophisticated eScribe merge field capabilities and an American Cancer Society clinician portal are among the new innovations showcased in Elekta's MOSAIQ® Oncology Information System (OIS) at the American Society of Clinical Oncology (ASCO) Annual Meeting, June 1-4, at McCormick Place in Chicago.
In addition, for the sixth consecutive year, Elekta (booth #4019) has been selected to demonstrate at ASCO's EHR Vendor Lab. The 2012 Lab will be a live, in-person resource held June 2-4 in the Oncology Professionals Hall, booth #5004.
MOSAIQ is designed to manage the complete spectrum of oncology treatments in a single patient record. For chemotherapy, MOSAIQ provides a clear, flexible way to chart the patient's treatment across the medical assessment and chemotherapy administration process.
New in MOSAIQ:
MOSAIQ is the first comprehensive, oncology-specific EMR certified for meaningful use under the federal government's American Recovery and Reinvestment Act. The latest version of MOSAIQ is optimized for practices planning to demonstrate meaningful use, which qualifies them to receive payments from the Centers for Medicare & Medicaid Services (CMS) under Medicare rules.
MOSAIQ ranked first in the 2011 Best in KLAS Awards: Software & Services report. KLAS's data also are supported by the U.S. News & World Report 2011-12 best hospital rankings, which indicate that 46 out of the 50 top-ranked cancer hospitals are users of Elekta's oncology software.
"Yearly, ASCO always attracts the top minds in oncology, and we're honored to support this event," says Todd Powell, Executive Vice President, Elekta Software. "We anticipate that visitors to the Elekta exhibit will see once again why MOSAIQ is the preferred OIS for thousands of oncology practices."
Learn more at www.elekta.com/mosaiq.
For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: email@example.com
Time zone: CET: Central European Time
Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: firstname.lastname@example.org
Time zone: ET: Eastern Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.
Copyright©2010 PR Newswire.
All rights reserved